South San Francisco, CA · Founded 2019 · Privately Held (backing)
Developer of a broad-spectrum vaccine designed to treat and eradicate rapidly mutating pathogens. Centivax is based in South San Francisco, CA and was founded in 2019. Its last reported valuation was $95 million in Jul 2025. It has raised $92 million.
Last reported valuation
$95.0M
Oct 2026
Priced at
—
Total raised
$92.0M
Last round
—
Team — not yet on record
No current team members for Centivax are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Centivax with a free account
·The complete investor list: 14 names
·Watch Centivax: the Monday email on marks, rounds and moves
